高级检索

2024—2025年深圳市龙岗区小学生接种三价灭活流感疫苗保护效果:基于监测数据的回顾性队列评价

Effectiveness of trivalent inactivated influenza vaccine among primary school students in Longgang district, Shenzhen city during the 2024–2025 influenza season: a retrospective cohort study based on surveillance data

  • 摘要:
    目的 评价2024—2025年广东省深圳市龙岗区小学生接种三价灭活流感疫苗(TIV)预防流行性感冒(简称“流感”)的保护效果(VE),为流感疫苗(InfV)公费项目的成本效果评价提供依据。
    方法 收集深圳市龙岗区学生健康监测信息系统、中国疾病预防控制信息系统和深圳市免疫规划信息管理系统中龙岗区2024年8月—2025年7月的在校小学生名单及其流感发病信息和InfV接种信息,按班级InfV接种率将学生分为<50.00%组、50.00%~74.99%组、75.00%~100%组和总体组,采用倾向性评分匹配法均衡TIV接种组和未接种组间协变量建立可比的现实世界回顾性队列,应用多因素Cox回归模型分析TIV预防流感的调整后VE(aVE)。
    结果 经倾向性评分匹配后,总体组中TIV接种组和未接种组各纳入研究对象159 336人,流感发病密度分别为1.40/100人年和2.35/100人年;班级InfV接种率为<50.00%组、50.00%~74.99%组、75.00%~100%组和总体组小学生接种TIV预防流感的aVE(95%CI)分别为29.83%(21.00%~37.67%)、37.84%(31.39%~43.67%)、41.06%(36.23%~45.53%)和40.31%(36.44%~43.95%);6~8岁和9~12岁小学生接种TIV预防流感的aVE(95%CI)分别为46.75%(42.22%~50.93%)和28.76%(21.34%~35.48%);上年度未接种InfV和接种过InfV小学生接种TIV预防流感的aVE(95%CI)分别为46.52%(41.15%~51.40%)和35.78%(30.20%~40.92%),小学生接种TIV预防甲型流感、乙型流感和甲乙型混合流感的aVE(95%CI)分别为42.33%(37.48%~46.80%)、35.64%(23.43%~45.90%)和21.00%(−22.46%~49.04%)。
    结论 2024—2025年深圳市龙岗区小学生接种TIV预防流感具有较好的保护效果,建议每年在流感流行季节来临前尽早接种InfV并维持较高的接种率。

     

    Abstract:
    Objective To evaluate the vaccine effectiveness (VE) of trivalent inactivated influenza vaccine (TIV) against influenza among primary school students in Longgang district, Shenzhen city, Guangdong province during the 2024–2025 academic year, thus providing evidence for the cost-effectiveness evaluation of publicly funded influenza vaccine (InfV) programs.
    Methods Data on the roster of in-school primary school students in Longgang district from August 2024 to July 2025, together with their influenza incidence and InfV vaccination records, were extracted from the Longgang District Student Health Monitoring Information System, the China Information System for Disease Control and Prevention, and the Shenzhen Immunization Program Information Management System. According to class-level InfV vaccination coverage, students were stratified into four groups: <50.00%, 50.00%–74.99%, 75.00%–100%, and an overall group. Propensity score matching (PSM) was employed to balance covariates between the TIV-vaccinated and unvaccinated groups, forming a comparable real-world retrospective cohort. Multivariable Cox regression models were employed to estimate the adjusted vaccine effectiveness (aVE) of TIV against influenza.
    Results After PSM, the overall group comprised 159 336 participants in both the TIV-vaccinated and unvaccinated groups, with influenza incidence densities of 1.40 and 2.35 per 100 person-years, respectively. The aVE (95%CI) of TIV against influenza by class-level vaccination coverage was 29.83% (21.00% to 37.67%) for the < 50.00% group, 37.84% (31.39% to 43.67%) for the 50.00%–74.99% group, 41.06% (36.23% to 45.53%) for the 75.00%–100% group, and 40.31% (36.44% to 43.95%) for the overall group. By age subgroups, the aVE (95%CI) was 46.75% (42.22% to 50.93%) for students of 6 to 8 years old and 28.76% (21.34% to 35.48%) for students of 9 to 12 years old. By vaccination history, the aVE (95%CI) was 46.52% (41.15% to 51.40%) for those unvaccinated the previous year and 35.78% (30.20% to 40.92%) for those vaccinated previously. Against influenza A, B, and mixed A+B, the aVE (95%CI) was 42.33% (37.48% to 46.80%), 35.64% (23.43% to 45.90%), and 21.00% (−22.46% to 49.04%), respectively.
    Conclusions TIV vaccination conferred substantial protective effects against influenza among primary school students in Longgang district during the 2024–2025 academic year. Annual timely administration of InfV before the influenza epidemic season and maintenance of high vaccination coverage are recommended.

     

/

返回文章
返回